WO2000066078A1 - Composition a destination cosmetique et/ou dietetique comprenant un melange de lycopene et d'extrait de feuille d'olivier - Google Patents
Composition a destination cosmetique et/ou dietetique comprenant un melange de lycopene et d'extrait de feuille d'olivier Download PDFInfo
- Publication number
- WO2000066078A1 WO2000066078A1 PCT/FR2000/001105 FR0001105W WO0066078A1 WO 2000066078 A1 WO2000066078 A1 WO 2000066078A1 FR 0001105 W FR0001105 W FR 0001105W WO 0066078 A1 WO0066078 A1 WO 0066078A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- composition
- extract
- cosmetic
- lycopene
- dietetic
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 100
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 title claims abstract description 37
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 title claims abstract description 37
- 235000012661 lycopene Nutrition 0.000 title claims abstract description 37
- 239000001751 lycopene Substances 0.000 title claims abstract description 37
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 title claims abstract description 37
- 229960004999 lycopene Drugs 0.000 title claims abstract description 37
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 title claims abstract description 37
- 239000002537 cosmetic Substances 0.000 title claims abstract description 26
- 230000000378 dietary effect Effects 0.000 title claims abstract description 26
- 235000005911 diet Nutrition 0.000 title claims abstract description 23
- 229940114496 olive leaf extract Drugs 0.000 title claims abstract description 20
- 238000000034 method Methods 0.000 claims abstract description 11
- 238000005063 solubilization Methods 0.000 claims abstract description 9
- 230000007928 solubilization Effects 0.000 claims abstract description 9
- 238000004519 manufacturing process Methods 0.000 claims abstract description 7
- 239000000284 extract Substances 0.000 claims description 40
- 235000020095 red wine Nutrition 0.000 claims description 23
- 240000007817 Olea europaea Species 0.000 claims description 20
- 235000007688 Lycopersicon esculentum Nutrition 0.000 claims description 19
- 238000009472 formulation Methods 0.000 claims description 15
- 239000008601 oleoresin Substances 0.000 claims description 13
- 239000000341 volatile oil Substances 0.000 claims description 12
- 235000002725 Olea europaea Nutrition 0.000 claims description 9
- 238000003756 stirring Methods 0.000 claims description 9
- 235000005979 Citrus limon Nutrition 0.000 claims description 8
- 244000131522 Citrus pyriformis Species 0.000 claims description 8
- 239000003921 oil Substances 0.000 claims description 7
- 235000019198 oils Nutrition 0.000 claims description 7
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Natural products OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 6
- 239000008187 granular material Substances 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- 241000894007 species Species 0.000 claims description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 5
- 241000208152 Geranium Species 0.000 claims description 5
- 230000003712 anti-aging effect Effects 0.000 claims description 5
- 150000002632 lipids Chemical class 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 claims description 4
- 235000017647 Brassica oleracea var italica Nutrition 0.000 claims description 4
- 240000007436 Cananga odorata Species 0.000 claims description 4
- 230000003078 antioxidant effect Effects 0.000 claims description 4
- 230000000694 effects Effects 0.000 claims description 4
- 235000008390 olive oil Nutrition 0.000 claims description 4
- 239000004006 olive oil Substances 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 4
- 230000000699 topical effect Effects 0.000 claims description 4
- 244000144725 Amygdalus communis Species 0.000 claims description 3
- 235000011437 Amygdalus communis Nutrition 0.000 claims description 3
- 240000003259 Brassica oleracea var. botrytis Species 0.000 claims description 3
- 235000005976 Citrus sinensis Nutrition 0.000 claims description 3
- 240000002319 Citrus sinensis Species 0.000 claims description 3
- 230000032683 aging Effects 0.000 claims description 3
- 239000008168 almond oil Substances 0.000 claims description 3
- 235000021324 borage oil Nutrition 0.000 claims description 3
- 235000008524 evening primrose extract Nutrition 0.000 claims description 3
- 239000010475 evening primrose oil Substances 0.000 claims description 3
- 229940089020 evening primrose oil Drugs 0.000 claims description 3
- 239000000845 maltitol Substances 0.000 claims description 3
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 claims description 3
- 229940035436 maltitol Drugs 0.000 claims description 3
- 235000010449 maltitol Nutrition 0.000 claims description 3
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 3
- 238000004321 preservation Methods 0.000 claims description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 3
- 230000001225 therapeutic effect Effects 0.000 claims description 3
- 239000010497 wheat germ oil Substances 0.000 claims description 3
- 230000037406 food intake Effects 0.000 claims description 2
- 239000002304 perfume Substances 0.000 claims description 2
- 241000227653 Lycopersicon Species 0.000 claims 5
- 240000003768 Solanum lycopersicum Species 0.000 description 14
- 239000000126 substance Substances 0.000 description 6
- 235000001412 Mediterranean diet Nutrition 0.000 description 4
- 201000001320 Atherosclerosis Diseases 0.000 description 3
- 208000001953 Hypotension Diseases 0.000 description 3
- 238000013019 agitation Methods 0.000 description 3
- 235000021466 carotenoid Nutrition 0.000 description 3
- 150000001747 carotenoids Chemical class 0.000 description 3
- 239000000812 cholinergic antagonist Substances 0.000 description 3
- 208000021822 hypotensive Diseases 0.000 description 3
- 150000008442 polyphenolic compounds Chemical class 0.000 description 3
- 235000013824 polyphenols Nutrition 0.000 description 3
- 230000001256 tonic effect Effects 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 2
- 230000002225 anti-radical effect Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 230000032677 cell aging Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 230000001077 hypotensive effect Effects 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 230000003711 photoprotective effect Effects 0.000 description 2
- 230000003449 preventive effect Effects 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000002048 spasmolytic effect Effects 0.000 description 2
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- DMASLKHVQRHNES-UPOGUZCLSA-N (3R)-beta,beta-caroten-3-ol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C DMASLKHVQRHNES-UPOGUZCLSA-N 0.000 description 1
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 description 1
- 244000308180 Brassica oleracea var. italica Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 239000004212 Cryptoxanthin Substances 0.000 description 1
- 240000004784 Cymbopogon citratus Species 0.000 description 1
- 235000017897 Cymbopogon citratus Nutrition 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 description 1
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 description 1
- 150000001491 aromatic compounds Chemical class 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 235000002360 beta-cryptoxanthin Nutrition 0.000 description 1
- DMASLKHVQRHNES-ITUXNECMSA-N beta-cryptoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CCCC2(C)C DMASLKHVQRHNES-ITUXNECMSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 229920002770 condensed tannin Polymers 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 235000019244 cryptoxanthin Nutrition 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- 229940087603 grape seed extract Drugs 0.000 description 1
- 235000002532 grape seed extract Nutrition 0.000 description 1
- 235000012680 lutein Nutrition 0.000 description 1
- 239000001656 lutein Substances 0.000 description 1
- 229960005375 lutein Drugs 0.000 description 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000001717 vitis vinifera seed extract Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
- 235000010930 zeaxanthin Nutrition 0.000 description 1
- 239000001775 zeaxanthin Substances 0.000 description 1
- 229940043269 zeaxanthin Drugs 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/31—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Definitions
- Cosmetic and / or dietetic composition comprising a mixture of lycopene and olive leaf extract
- the present invention firstly relates to a composition for cosmetic and / or dietetic purposes. It also relates to a use of the composition for the preparation of a cosmetic formulation with anti-aging properties and a use of an ingestible formulation with dietetic and in particular hypotensive-spasmolytic properties, preventive of anti-oxidant and anti-radical atherosclerosis. , protective of collagen, slowing down the cell aging process.
- the invention finally relates to a cosmetic and dietetic process as well as a process for manufacturing a composition according to the invention.
- the invention will find its application particularly in the field of the manufacture of cosmetic and dietetic products and mainly in the context of the development of such products from vegetable raw materials. Some properties of lycopene are already known.
- Said skin pigmentation regulating composition of the type comprising carotenoids, essentially comprises a component consisting of at least one carotenoid of natural origin with provitaminic activity, selected from the group consisting of beta-carotene and betaalphacarotene or a mixture thereof and a component corresponding to at least one carotenoid of natural origin without provitaminic activity, constituted by lycopene, possibly associated with another component, selected from the group constituted by zeaxanthin, cryptoxanthin and lutein or a mixture thereof, the components and the lycopene being in a ratio of between 0, 95/1 and 1/50.
- lycopene is a very difficult substance to dissolve. Its use is therefore delicate and the compositions currently obtained are not always homogeneous and stable.
- Lycopene can also be used in combination with other elements allowing a synergistic action.
- One of the first objects of the invention is to use lycopene in combination with other substances and particularly with olive leaf extract and dry red wine extract.
- the advantage of such a combination is to create a good solubilization of lycopene and to associate the properties of the two substances with the protective properties of polyphenols in red wine.
- the invention presented here has the advantage of having properties of both anti-aging and dietary maintenance.
- the invention has the advantage of being able to be in different forms, in particular in the form of ingestible granules or else in the form of an oil which can be applied topically.
- composition according to the invention can be prepared from entirely natural components such as tomatoes, olive leaves and red wine.
- the cosmetic and / or dietetic composition is characterized in that it comprises an active mixture of lycopene and olive leaf extract, the olive leaf extract allowing the solubilization of lycopene and combining its effects of lipid regulation to those of preservation of lycopene cells.
- the invention also relates to the use of a composition for the preparation of a cosmetic formulation with anti-aging properties.
- the invention also relates to the use of a composition for the preparation of an ingestible formulation with dietetic properties avoiding excess lipids and aging.
- the cosmetic and dietetic treatment process excluding any therapeutic treatment is characterized by the fact that it consists in using an active lycopene-olive leaf extract mixture both for external topical use and for internal use by ingestion. .
- the process for manufacturing a composition is characterized by the fact that the active mixture is produced by - incorporating the concentrated olive extract of the tomato oleoresin under agitation and in small parts maintaining agitation to optimize the solubilization - preparing a 25% m / m solution of dry red wine extract in a water / alcohol mixture at 50% v / v - incorporating the red wine solution into the solution of tomato oleoresin and leaf extract olive tree at low speed and with stirring.
- the composition presented here can be implemented in the embodiments set out below.
- the active mixture comprises one or more polyphenolic species with antioxidant properties. Lycopene is made from tomato extract.
- the polyphenolic species are obtained from red wine.
- the composition is in the form of granules.
- the composition is in the form of an oil. It presents the following formulation, in weight proportions: lemon extract: 5 to 10% tomato oleoresin with 6% lycopene: 5 to 10% olive extract: 5 to 10% dry red wine extract: 1 to 5%
- composition has the following formulation, in weight proportions:
- composition according to the invention can be used in the cosmetic field and in the dietetic field. This composition firstly comprises an active mixture.
- This active mixture combines lycopene and olive leaf extract.
- lycopene this substance has antioxidant and anti-radical properties. It can be obtained from tomato extract.
- 1 tomato oleoresin includes lycopene.
- the active mixture also includes olive leaf extract.
- This extract has an action of lowering the cholesterol level and preventing cardiovascular diseases. It is hypotensive, spasmolytic and prevents atherosclerosis.
- the olive oil present in the cosmetic is rich in polyasaturated fatty acids with beneficial properties for the maintenance of the skin.
- composition according to the invention it is possible to use olive leaf extract from leaf powder.
- the olive leaf extract has the particularly advantageous property of allowing the lycopene to dissolve.
- lycopene and olive leaf extract combine their complementary effects in terms of cell preservation and lipid regulation.
- Red wine extract can further strengthen this association.
- the active mixture also comprises one or more polyphenolic species with: total polyphenols: 92% (catechin equivalent), - Proanthocyanidols: 45% minimum.
- the red wine extract contains approximately 46% proanthocyanidols.
- grape seed extract containing for its part more than 50% of proanthocyanidins.
- an active mixture is formed in equal proportions by weight of tomato oleoresin, concentrated olive extract and dry red wine extract.
- the concentrated olive extract will be obtained from olive leaf powder and concentrated four times more.
- red wine extract it may be a dry extract incorporated at 25% in a solution at 50% by volume of water and alcohol.
- An advantage of the present composition is its flexibility of use both in ingestible form and in external form.
- composition in the form of granules or also in the form of an oil.
- the following formulation may be used in weight proportions: lemon extract: 5 to 10%; lemon is a good binder and an interesting aromatic compound, tomato oleoresin at 6% Lycopene: 5 to 10%; the tomato in fact comprises lycopene and constitutes an entirely natural raw material present in particular in Mediterranean diets, olive extract: 5 to 10%; the olive extract can also come from the Mediterranean diet.
- - Broccoli 1 to 5%; broccoli has the advantage of having detoxifying properties.
- Citric acid 1 to 3%.
- sodium carbonate 1 to 3
- essential oils of sweet orange 1 to 3%
- - Flavor 0.3 to 1%
- the composition may have the following formulation, in weight proportions: - 0.01 to 1% of a mixture of lycopene, olive leaf and extract of Red wine,
- - vegetable oils including sweet almond oil, olive oil, wheat germ oil, evening primrose oil and borage oil, - essential oils such as Ylang-Ylang 0.1 to 0.5% Geranium 0, 1 to 0.5% of Lemon 0.1 to 0.5%.
- a fragrance can be added at a level of 0.3 to 1%.
- Essential oils are an important contribution to the present composition.
- geranium essential oil is a tonic and skin regenerator.
- Ylang-Ylang essential oil also has a tonic and regenerating action on the skin. It is particularly active in combination with geranium essential oil and is an excellent hair tonic.
- the lemon essential oil it avoids facial wrinkles and maintains the softness of the hands.
- the invention also relates to a use of the composition.
- a composition in the form of an oil or also in the form of a cream in accordance with the formulation using vegetable oils and essential oils as indicated above, the composition may be used for the preparation of a cosmetic formulation with anti-aging properties.
- the invention further relates to a use of a composition according to the invention in ingestible form.
- This form may be granules, we can also use any form capable of being sucked, chewed, swallowed, drunk or dissolved to be ingested.
- composition with particularly hypotensive, spasmolytic dietetic properties, preventive of atherosclerosis.
- composition according to the invention can be used in internal form and for external use.
- the invention relates to a cosmetic and dietetic treatment process, excluding any therapeutic treatment.
- This process consists in using both in external use and in internal use the active mixture of lycopene and extract olive leaf and preferably red wine extract.
- the process presented here has the advantage of allowing effective solubilization of lycopene in the extract of olive leaf.
- the active mixture of the composition according to the invention is produced by the following steps: the concentrated olive extract is incorporated with tomato oleoresin with stirring and in small portions.
- Tomato oleoresin includes lycopene.
- the incorporation into the olive extract with stirring and in small parts allows a gradual dissolution of the two components. - Stirring is maintained to optimize the solubilization.
- the duration of agitation may be of the order of one hour.
- a solution of dry extract of red wine is prepared in parallel with stirring. A clear solution is thus obtained capable of being incorporated into the preceding solution of lycopene and of olive leaf extract.
- This latter incorporation will preferably be carried out at low speed and with stirring in order to obtain a perfectly homogeneous final composition.
- the invention has the advantage of using entirely natural components which are part of the Mediterranean diet (red wine extract, tomato and olive leaf extract).
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Botany (AREA)
- Dermatology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Food Science & Technology (AREA)
- Toxicology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Nutrition Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Polymers & Plastics (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000614964A JP2002543103A (ja) | 1999-04-28 | 2000-04-26 | リコピンとオリーブ葉エキスとの混合物を含む、美容用及び/又はダイエット用組成物 |
AU43048/00A AU4304800A (en) | 1999-04-28 | 2000-04-26 | Cosmetic and/or dietetic composition comprising a mixture of lycopene and olive leaf extract |
EP00922754A EP1173149A1 (fr) | 1999-04-28 | 2000-04-26 | Composition a destination cosmetique et/ou dietetique comprenant un melange de lycopene et d'extrait de feuille d'olivier |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR99/05343 | 1999-04-28 | ||
FR9905343A FR2792831B1 (fr) | 1999-04-28 | 1999-04-28 | Composition a destination cosmetique et/ou dietetique comprenant un melange de lycopene et d'extrait de feuille d'olivier |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2000066078A1 true WO2000066078A1 (fr) | 2000-11-09 |
Family
ID=9544936
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/FR2000/001105 WO2000066078A1 (fr) | 1999-04-28 | 2000-04-26 | Composition a destination cosmetique et/ou dietetique comprenant un melange de lycopene et d'extrait de feuille d'olivier |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1173149A1 (fr) |
JP (1) | JP2002543103A (fr) |
AU (1) | AU4304800A (fr) |
FR (1) | FR2792831B1 (fr) |
WO (1) | WO2000066078A1 (fr) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2813525A1 (fr) * | 2000-09-07 | 2002-03-08 | Silab Sa | Procede d'extraction d'un principe actif a partir de feuilles d'olea europaea pour favoriser la synthese de proteines de stress, principe actif obtenu |
JP2004059518A (ja) * | 2002-07-30 | 2004-02-26 | Enkaku Iryo Kenkyusho:Kk | 筋蛋白分解抑制剤および機能性飲食品 |
FR2846235A1 (fr) * | 2002-10-29 | 2004-04-30 | Oreal | Procede cosmetique de lissage des rides d'expression par application topique d'une composition de parfum |
JP2004520374A (ja) * | 2001-01-23 | 2004-07-08 | ライコード・ナチユラル・プロダクツ・インダストリーズ・リミテツド | 血圧降下剤としてのカロテノイド |
WO2005000041A1 (fr) * | 2003-06-27 | 2005-01-06 | Indena S.P.A. | Combinaisons d'agents vasoprotecteurs et formulations les contenant |
EP1317272B1 (fr) * | 2000-05-25 | 2006-04-12 | Boehringer Ingelheim International GmbH | Composition contenant un antioxidant lipophile et un antioxidant hydrophyle destinee a ameliorer la protection cellulaire |
WO2007010216A1 (fr) * | 2005-07-21 | 2007-01-25 | Cambridge Theranostics Limited | Formulations de lycopene pour le traitement de maladies atherosclereuses |
JP2008273979A (ja) * | 2002-05-07 | 2008-11-13 | Access Business Group Internatl Llc | 植物栄養素栄養サプリメント |
EP1790234B1 (fr) * | 2005-11-28 | 2014-07-02 | Chr. Hansen A/S | Additif antioxydant naturel pour la nourriture ou pour l'eau potable pour animaux |
US10603332B2 (en) | 2013-09-30 | 2020-03-31 | Sunstar Inc. | Anti-obesity composition |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2810887B1 (fr) * | 2000-06-29 | 2005-03-18 | Seporga Lab | Preparations cosmetiques ou dermo-pharmaceutiques renfermant un extrait de feuilles d'olivier qui protege les cellules des agressions |
ES2172442B2 (es) * | 2000-11-15 | 2003-12-01 | Univ Extremadura | Procedimiento para la produccion de un concentrado de licopeno libre de disolventes organicos, concentrado obtenido y composicion que comprende dicho concentrado. |
FR2829927B1 (fr) * | 2001-09-21 | 2004-09-24 | Svr Lab | Nouvelles compositions cosmetiques et leur procede d'obtention |
ATE340557T1 (de) * | 2002-06-05 | 2006-10-15 | Grazyna Ziegler-Janoschka | Mittel zur äusserlichen anwendung beim menschen |
JP2009159929A (ja) * | 2007-12-13 | 2009-07-23 | Fujifilm Corp | 油性組成物 |
CN105795303A (zh) * | 2016-03-16 | 2016-07-27 | 袁云峰 | 润肠通便颗粒剂及其制备方法 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0659402A2 (fr) * | 1993-12-21 | 1995-06-28 | INDENA S.p.A. | Compositions contenant de caroténoides et de procaroténoides en association avec des polyphénoles pour la prévention de dommages provoqués par la production anormale des radicaux libres |
GB2317561A (en) * | 1996-09-20 | 1998-04-01 | Howard Foundation | Plant derived composition containing flavanoid compounds |
WO1999018814A1 (fr) * | 1997-10-14 | 1999-04-22 | Quest International B.V. | Preparation permettant d'accroitre le statut antioxydant de cellules |
FR2770974A1 (fr) * | 1997-11-20 | 1999-05-21 | Hatem Smaoui | Nouveau complement nutritionnel a base de lycopene de tomate, d'acides gras r 3-6-9 et antioxydants primaires et secondaires |
FR2772235A1 (fr) * | 1997-12-12 | 1999-06-18 | Fabre Pierre Sante | Composition polyphenolique, utile comme complement alimentaire, nutraceutique ou composition cosmetique |
WO1999048386A1 (fr) * | 1998-03-24 | 1999-09-30 | Stueckler Franz | Produit a base de substances naturelles |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0978061A (ja) * | 1995-09-18 | 1997-03-25 | ヤヱガキ醗酵技研株式会社 | 抗酸化剤 |
-
1999
- 1999-04-28 FR FR9905343A patent/FR2792831B1/fr not_active Expired - Fee Related
-
2000
- 2000-04-26 JP JP2000614964A patent/JP2002543103A/ja active Pending
- 2000-04-26 EP EP00922754A patent/EP1173149A1/fr not_active Withdrawn
- 2000-04-26 AU AU43048/00A patent/AU4304800A/en not_active Abandoned
- 2000-04-26 WO PCT/FR2000/001105 patent/WO2000066078A1/fr not_active Application Discontinuation
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0659402A2 (fr) * | 1993-12-21 | 1995-06-28 | INDENA S.p.A. | Compositions contenant de caroténoides et de procaroténoides en association avec des polyphénoles pour la prévention de dommages provoqués par la production anormale des radicaux libres |
GB2317561A (en) * | 1996-09-20 | 1998-04-01 | Howard Foundation | Plant derived composition containing flavanoid compounds |
WO1999018814A1 (fr) * | 1997-10-14 | 1999-04-22 | Quest International B.V. | Preparation permettant d'accroitre le statut antioxydant de cellules |
FR2770974A1 (fr) * | 1997-11-20 | 1999-05-21 | Hatem Smaoui | Nouveau complement nutritionnel a base de lycopene de tomate, d'acides gras r 3-6-9 et antioxydants primaires et secondaires |
FR2772235A1 (fr) * | 1997-12-12 | 1999-06-18 | Fabre Pierre Sante | Composition polyphenolique, utile comme complement alimentaire, nutraceutique ou composition cosmetique |
WO1999048386A1 (fr) * | 1998-03-24 | 1999-09-30 | Stueckler Franz | Produit a base de substances naturelles |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1317272B1 (fr) * | 2000-05-25 | 2006-04-12 | Boehringer Ingelheim International GmbH | Composition contenant un antioxidant lipophile et un antioxidant hydrophyle destinee a ameliorer la protection cellulaire |
FR2813525A1 (fr) * | 2000-09-07 | 2002-03-08 | Silab Sa | Procede d'extraction d'un principe actif a partir de feuilles d'olea europaea pour favoriser la synthese de proteines de stress, principe actif obtenu |
JP2010180220A (ja) * | 2001-01-23 | 2010-08-19 | Lycored Natural Products Industries Ltd | 血圧降下剤としてのカロテノイド |
JP2004520374A (ja) * | 2001-01-23 | 2004-07-08 | ライコード・ナチユラル・プロダクツ・インダストリーズ・リミテツド | 血圧降下剤としてのカロテノイド |
JP2008273979A (ja) * | 2002-05-07 | 2008-11-13 | Access Business Group Internatl Llc | 植物栄養素栄養サプリメント |
JP2004059518A (ja) * | 2002-07-30 | 2004-02-26 | Enkaku Iryo Kenkyusho:Kk | 筋蛋白分解抑制剤および機能性飲食品 |
EP1415644A1 (fr) * | 2002-10-29 | 2004-05-06 | L'oreal | Procédé cosmétique de lissage des rides d'expression par application topique d'une composition de parfum |
FR2846235A1 (fr) * | 2002-10-29 | 2004-04-30 | Oreal | Procede cosmetique de lissage des rides d'expression par application topique d'une composition de parfum |
WO2005000041A1 (fr) * | 2003-06-27 | 2005-01-06 | Indena S.P.A. | Combinaisons d'agents vasoprotecteurs et formulations les contenant |
AU2004251009B2 (en) * | 2003-06-27 | 2010-06-17 | Indena S.P.A. | Combinations of vasoprotective agents and formulations containing them |
US8206759B2 (en) | 2003-06-27 | 2012-06-26 | Indena S.P. A. | Method of reducing blood cholesterol and triglyceride levels using combinations of vasoprotective agent |
WO2007010216A1 (fr) * | 2005-07-21 | 2007-01-25 | Cambridge Theranostics Limited | Formulations de lycopene pour le traitement de maladies atherosclereuses |
EA013465B1 (ru) * | 2005-07-21 | 2010-04-30 | Кембридж Тераностикс Лимитед | Ликопиновые композиции для лечения атеросклеротических состояний |
EP1790234B1 (fr) * | 2005-11-28 | 2014-07-02 | Chr. Hansen A/S | Additif antioxydant naturel pour la nourriture ou pour l'eau potable pour animaux |
US10603332B2 (en) | 2013-09-30 | 2020-03-31 | Sunstar Inc. | Anti-obesity composition |
Also Published As
Publication number | Publication date |
---|---|
EP1173149A1 (fr) | 2002-01-23 |
AU4304800A (en) | 2000-11-17 |
FR2792831A1 (fr) | 2000-11-03 |
FR2792831B1 (fr) | 2001-08-03 |
JP2002543103A (ja) | 2002-12-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0278809B1 (fr) | Nouvelles compositions cosmétiques ou dermatologiques renfermant un extrait des fruits de Silybum Marianum riche en Silymarine associé à des acides gras essentiels | |
WO2000066078A1 (fr) | Composition a destination cosmetique et/ou dietetique comprenant un melange de lycopene et d'extrait de feuille d'olivier | |
WO1988009654A1 (fr) | Composition a base d'extrait de murier | |
KR100358210B1 (ko) | 항-라디칼활성을가지는오렌지추출물을포함하는미용조성물 | |
WO2010146294A1 (fr) | Extrait de végétal pour la fabrication de composition de contrôle de la mélanogénèse, composition de contrôle obtenue et procédé de contrôle mettant en œuvre une telle composition | |
CA2312433A1 (fr) | Compositions pour la coloration artificielle de la peau et utilisations | |
FR3060983A1 (fr) | Procede de traitement des fibres keratiniques mettant en oeuvre des polyphenols, des aldehydes et/ou sucres, des hydroxydes et/ou (hydrogeno)carbonates et des sels metalliques particuliers | |
WO2020008151A1 (fr) | Composition huileuse contenant un extrait de mimosa tenuiflora et utilisations | |
FR2954143A1 (fr) | Procede de traitement cosmetique des peaux relachees | |
KR102088597B1 (ko) | 커피 추출물을 포함하는 염모제 조성물 | |
EP3082464B1 (fr) | Composition comprenant des extraits de raisin tannat ou cannonau, procédé d'extraction et utilisations | |
CA2252633A1 (fr) | Compositions cosmetiques et/ou pharmaceutiques et/ou dermatologiques | |
KR102103108B1 (ko) | 녹차 추출물을 포함하는 염모제 조성물 | |
EP3068496B1 (fr) | Composition huileuse a base d'extraits lipophiles de rose de porcelaine et de jacinthe d'eau | |
KR101457068B1 (ko) | 돼지껍데기로부터 추출된 콜라겐단백질을 이용한 천연 마사지팩 제조방법 | |
WO2009125117A2 (fr) | Composition dermatologique utilisable notamment pour le soin et la prevention des escarres | |
EP2403474B1 (fr) | Composition cosmétique pour lutter contre le vieillissement de la peau, constituée et distribuée sous la forme d'une poudre se transformant en crème lors de son application | |
WO2011073941A1 (fr) | Utilisation d'un polymere a titre d'agent antioxydant | |
EP3229923B1 (fr) | Utilisation cosmétique d'un extrait d'eschscholtzia californica | |
FR3123807A1 (fr) | Serum cosmetique activateur et utilisation dans un procede de soin cosmetique | |
FR2843879A1 (fr) | Nouvelles compositions cosmetiques a visee anti-oxydante | |
FR3117368A1 (fr) | Extrait d’au moins une plante de l’espèceCrocus sativus comprenant un fort taux de crocines et un faible taux de safranal, et son utilisation cosmétique à titre d’agent antioxydant | |
WO2003059243A2 (fr) | Composition cosmetique pour lutter contre le vieillissement cutane | |
WO2015049266A1 (fr) | Utilisation d'une composition huileuse contenant un extrait d'hemerocalle pour ameliorer l'eclat du teint | |
FR2986966A1 (fr) | Composition cosmetique et/ou dermatologique contenant des activateurs de sirtuines |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2000922754 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 2000 614964 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09959523 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 2000922754 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2000922754 Country of ref document: EP |